These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. Yokokawa J, Saito H, Kanno Y, Honma F, Monoe K, Sakamoto N, Abe K, Takahashi A, Yokokawa H, Ohira H. J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953 [Abstract] [Full Text] [Related]
4. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. Ozaslan E, Efe C, Akbulut S, Purnak T, Savas B, Erden E, Altiparmak E. Hepatogastroenterology; 2010 Feb; 57(99-100):441-6. PubMed ID: 20698205 [Abstract] [Full Text] [Related]
5. Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. Suzuki Y, Arase Y, Ikeda K, Saitoh S, Tsubota A, Suzuki F, Kobayashi M, Akuta N, Someya T, Miyakawa Y, Kumada H. J Gastroenterol Hepatol; 2004 Jun; 19(6):699-706. PubMed ID: 15151627 [Abstract] [Full Text] [Related]
6. [Clinical and pathological characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis]. Zhu GJ, Chen S, Mao Q, Wang YM. Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):6-8. PubMed ID: 15670481 [Abstract] [Full Text] [Related]
7. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Chazouillères O, Wendum D, Serfaty L, Rosmorduc O, Poupon R. J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577 [Abstract] [Full Text] [Related]
8. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome]. Zeng Z, Han YK, Zhang XF, Geng H. Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480 [Abstract] [Full Text] [Related]
9. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ. Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416 [Abstract] [Full Text] [Related]
10. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F, Akarca US, Ersöz G, Karasu Z, Yüce G, Batur Y. Hepatogastroenterology; 2002 Feb; 49(47):1195-200. PubMed ID: 12239904 [Abstract] [Full Text] [Related]
12. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Muratori P, Granito A, Pappas G, Pendino GM, Quarneti C, Cicola R, Menichella R, Ferri S, Cassani F, Bianchi FB, Lenzi M, Muratori L. Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855 [Abstract] [Full Text] [Related]
13. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome]. Qiu DK, Li XM, Wei J, Ye LJ, Peng YS, Ma X. Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851 [Abstract] [Full Text] [Related]
14. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients]. Cheikh I, Said Y, Chaabouni H, Ouerghi H, Ben Ammar A. Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654 [Abstract] [Full Text] [Related]